TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Sporimed AB
Closing information (x1000 EUR)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
2
|
2
|
1 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
0
|
1
|
0 |
| EBITDA |
0
|
1
|
0 |
| Total assets |
6
|
7
|
10 |
| Current assets |
6
|
7
|
10 |
| Current liabilities |
0
|
1
|
1 |
| Equity capital |
6
|
6
|
9 |
| - share capital |
4
|
4
|
5 |
| Employees (average) |
0
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
100%
|
85.7%
|
90.0% |
| Turnover per employee |
2
|
1 | |
| Profit as a percentage of turnover |
0%
|
50.0%
|
0% |
| Return on assets (ROA) |
0%
|
14.3%
|
0% |
| Current ratio |
700%
|
1000% | |
| Return on equity (ROE) |
0%
|
16.7%
|
0% |
| Change turnover |
0
|
0
|
1 |
| Change turnover % |
6%
|
42% | |
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-100%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.